title: Insulin signaling in fatty acid and fat synthesis: a transcriptional perspective.
abstract: Transcription of enzymes involved in FA and TAG synthesis is coordinately induced in lipogenic tissues by feeding and insulin treatment. The three major transcription factors involved are USF, SREBP-1c, and LXRα. New insights into the insulin-signaling pathway(s) that control(s) lipogenic gene transcription via these factors have recently been revealed. Dephosphorylation/activation of DNA-PK by PP1 causes phosphorylation of USF that in turn recruits P/CAF to be acetylated for transcriptional activation. SREBP-1c can be induced by mTORC1, bifurcating lipogenesis from AKT-activated gluconeogenesis. LXRα may serve as a glucose sensor and, along with ChREBP, may activate lipogenic genes in the fed state. Dysregulation of FA and TAG metabolism often contributes to metabolic diseases such as obesity, diabetes, and cardiovascular diseases. Transcription factors and signaling molecules involved in transcriptional activation of FA and TAG synthesis represent attractive targets for the prevention and treatment of metabolic diseases.
authors.affiliation: Department of Nutritional Science and Toxicology, and Comparative Biochemistry Program, University of California, Berkeley, CA 94720, USA.
authors.forename: Roger H F
authors.initials: RH
authors.lastname: Wong
authors.forename: Hei Sook
authors.initials: HS
authors.lastname: Sul
mesh_terms: D005227:Fatty Acids / Q000096:biosynthesis* / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D000071518:Liver X Receptors; D008659:Metabolic Diseases / Q000188:drug therapy / Q000517:prevention & control; D058990:Molecular Targeted Therapy; D057093:Orphan Nuclear Receptors / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D051780:Sterol Regulatory Element Binding Protein 1 / Q000378:metabolism; D014158:Transcription, Genetic / Q000187:drug effects; D015533:Transcriptional Activation; D014280:Triglycerides / Q000096:biosynthesis* / Q000378:metabolism; D051720:Upstream Stimulatory Factors / Q000378:metabolism
chemical_list: D005227:Fatty Acids; D007328:Insulin; D000071518:Liver X Receptors; C000605213:NR1H3 protein, human; D057093:Orphan Nuclear Receptors; D051780:Sterol Regulatory Element Binding Protein 1; D014280:Triglycerides; D051720:Upstream Stimulatory Factors
references.citation: Genes Dev. 2010 Jul 1;24(13):1403-17
references.pmid: 20595232
references.citation: Cell. 2009 Mar 20;136(6):1056-72
references.pmid: 19303849
references.citation: Nature. 2007 Jan 11;445(7124):219-23
references.pmid: 17187055
references.citation: Proc Natl Acad Sci U S A. 1998 May 26;95(11):5987-92
references.pmid: 9600904
references.citation: Cell Metab. 2006 May;3(5):343-53
references.pmid: 16679292
references.citation: J Biol Chem. 1998 Dec 25;273(52):35299-306
references.pmid: 9857071
references.citation: Prog Lipid Res. 2010 Oct;49(4):343-52
references.pmid: 20363253
references.citation: Annu Rev Nutr. 2007;27:179-92
references.pmid: 17428181
references.citation: J Biol Chem. 2009 Oct 16;284(42):28510-21
references.pmid: 19720831
references.citation: J Biol Chem. 1997 Oct 17;272(42):26367-74
references.pmid: 9334210
references.citation: Nat Genet. 2004 Apr;36(4):371-6
references.pmid: 14991056
references.citation: J Clin Invest. 1998 Jan 1;101(1):1-9
references.pmid: 9421459
references.citation: Exp Biol Med (Maywood). 2005 Oct;230(9):593-605
references.pmid: 16179727
references.citation: Cell Cycle. 2009 Jul 1;8(13):1977-8
references.pmid: 19550139
references.citation: Science. 2001 Nov 30;294(5548):1866-70
references.pmid: 11729302
references.citation: Recent Prog Horm Res. 2001;56:157-73
references.pmid: 11237211
references.citation: J Biol Chem. 2007 Feb 23;282(8):5453-67
references.pmid: 17197698
references.citation: FEBS Lett. 2006 Sep 4;580(20):4835-41
references.pmid: 16904112
references.citation: Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3281-2
references.pmid: 20167806
references.citation: Science. 2009 May 22;324(5930):1029-33
references.pmid: 19460998
references.citation: Science. 1997 Mar 7;275(5305):1475-8
references.pmid: 9045612
references.citation: Cell. 1993 Oct 8;75(1):187-97
references.pmid: 8402897
references.citation: J Biol Chem. 2002 Mar 22;277(12):10691-7
references.pmid: 11781314
references.citation: J Biol Chem. 1999 Jan 22;274(4):2009-13
references.pmid: 9890958
references.citation: Cell Metab. 2007 Mar;5(3):159-61
references.pmid: 17339022
references.citation: Nat Rev Mol Cell Biol. 2006 Feb;7(2):85-96
references.pmid: 16493415
references.citation: Mol Cell Biol. 2003 Aug;23(16):5896-907
references.pmid: 12897158
references.citation: Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3441-6
references.pmid: 20133650
references.citation: J Clin Invest. 2002 May;109(9):1125-31
references.pmid: 11994399
references.citation: J Biol Chem. 1995 Dec 1;270(48):28716-22
references.pmid: 7499393
references.citation: Diabetes Metab. 2008 Dec;34(6 Pt 2):643-8
references.pmid: 19195625
references.citation: Curr Opin Clin Nutr Metab Care. 2008 Jul;11(4):483-90
references.pmid: 18542011
references.citation: J Biol Chem. 2000 Oct 27;275(43):33302-7
references.pmid: 10915800
references.citation: J Biol Chem. 2007 Apr 20;282(16):11687-95
references.pmid: 17296605
references.citation: Mol Endocrinol. 2007 Nov;21(11):2687-97
references.pmid: 17684114
references.citation: J Nutr. 2000 Feb;130(2S Suppl):315S-320S
references.pmid: 10721895
references.citation: Mol Cancer Ther. 2008 Feb;7(2):263-70
references.pmid: 18281512
references.citation: J Physiol Pharmacol. 2008 Dec;59 Suppl 7:31-55
references.pmid: 19258656
references.citation: Curr Opin Gastroenterol. 2010 May;26(3):202-8
references.pmid: 20168226
references.citation: J Biol Chem. 1998 Sep 25;273(39):25420-6
references.pmid: 9738010
references.citation: Science. 2006 Jun 23;312(5781):1798-802
references.pmid: 16794079
references.citation: Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10619-24
references.pmid: 10962028
references.citation: Cell Metab. 2005 Jun;1(6):379-91
references.pmid: 16054087
references.citation: J Clin Invest. 2008 Mar;118(3):956-64
references.pmid: 18292813